Exact Mass: 802.3904378

Exact Mass Matches: 802.3904378

Found 51 metabolites which its exact mass value is equals to given mass value 802.3904378, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dermorphin

Dermorphin

C40H50N8O10 (802.364972)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides Dermorphin is a natural heptapeptide μ-opioid receptor (MOR) agonist found in amphibian skin. Inhibition of neuropathic pain[1]. Dermorphin is a natural heptapeptide μ-opioid receptor (MOR) agonist found in amphibian skin. Inhibition of neuropathic pain[1]. Dermorphin is a natural heptapeptide μ-opioid receptor (MOR) agonist found in amphibian skin. Inhibition of neuropathic pain[1].

   

Dermorphin

2-amino-N-(1-{[1-({[(1-{2-[(1-carbamoyl-2-hydroxyethyl)carbamoyl]pyrrolidin-1-yl}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)carbamoyl]methyl}carbamoyl)-2-phenylethyl]carbamoyl}ethyl)-3-(4-hydroxyphenyl)propanamide

C40H50N8O10 (802.364972)


   

Streptovirudin B2

Streptovirudin B2

C36H58N4O16 (802.3847628)


   

Ipomoeassin A

Ipomoeassin A

C42H58O15 (802.3775518)


   

Tribestin

Tribestin

C39H62O15S (802.3809222)


   

Russelioside G

Russelioside G

C43H62O14 (802.4139352)


   

(25S)-spirost-5-ene-7-keto-1beta,3beta-diol 1-O-alpha-L-rhamnopyranosyl-(1->2)-(4-O-sulfo)-alpha-L-arabinopyranoside|angudracanoside A

(25S)-spirost-5-ene-7-keto-1beta,3beta-diol 1-O-alpha-L-rhamnopyranosyl-(1->2)-(4-O-sulfo)-alpha-L-arabinopyranoside|angudracanoside A

C38H58O16S (802.3445388)


   

ruscogenin 1-O-alpha-L-rhamnopyranosyl(1->2)-4-O-sulfo-beta-D-fucopyranoside

ruscogenin 1-O-alpha-L-rhamnopyranosyl(1->2)-4-O-sulfo-beta-D-fucopyranoside

C39H62O15S (802.3809222)


   

Leptaculatin

Leptaculatin

C40H66O16 (802.4350636)


   

C44H54N2O10S

C44H54N2O10S (802.3498984000001)


   

deistelianoside A|diosgenin 3-O-[3-O-sulfate-alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranoside

deistelianoside A|diosgenin 3-O-[3-O-sulfate-alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranoside

C39H62O15S (802.3809222)


   

C39H62O17

C39H62O17 (802.3986802)


   

23-galloylarjunolic acid 28-O-beta-D-glucopyranosyl ester

23-galloylarjunolic acid 28-O-beta-D-glucopyranosyl ester

C43H62O14 (802.4139352)


   

plocoside A

plocoside A

C40H66O16 (802.4350636)


   

trans-2-tridecanoyl tunicamycin

trans-2-tridecanoyl tunicamycin

C36H58N4O16 (802.3847628)


   

ecdysteroside

ecdysteroside

C40H66O16 (802.4350636)


   

C41H54O16

C41H54O16 (802.3411684)


   

Tunicamycin I

Tunicamycin I

C36H58N4O16 (802.3847628)


   

angudracanoside D

angudracanoside D

C38H58O16S (802.3445388)


   

C36H66O19

C36H66O19 (802.4198086)


   

Atazanavir sulfate

Atazanavir sulfate

C38H54N6O11S (802.3571094)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

Trityl Olmesartan Medoxomil

Trityl Olmesartan Medoxomil

C48H46N6O6 (802.3478656)


   

Glycoside O-4

Glycoside O-4

C39H62O15S (802.3809222)


   

(23S,25R)-12alpha,14alpha,17alpha,23-tetrahydroxyspirost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside

(23S,25R)-12alpha,14alpha,17alpha,23-tetrahydroxyspirost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside

C40H66O16 (802.4350636)


   

(E)-N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-11-methyldodec-2-enamide

(E)-N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-11-methyldodec-2-enamide

C36H58N4O16 (802.3847628)


   

Reyataz

Reyataz

C38H54N6O11S (802.3571094)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

tunicamycin A0

tunicamycin A0

C36H58N4O16 (802.3847628)


A nucleoside that is one of the homologues in the mixture that is tunicamycin, characterised by an 11-methyldodec-2-enoyl fatty acyl substituent on the amino group of the tunicamine moiety.

   

CID 168510851

CID 168510851

C31H54N12O13 (802.3933114)


   

[(2S,3S,6S)-6-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C43H62O12S (802.3961772)


   

DLCL(27:2)

DLCL(11:2_16:0)

C36H68O15P2 (802.4033238000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

LPIP2 O-22:0

LPIP2 O-22:0

C31H65O17P3 (802.3434430000001)


   

PI O-31:6;O2

PI O-31:6;O2

C40H67O14P (802.4268212)


   

PI P-18:1/13:4;O2

PI P-18:1/13:4;O2

C40H67O14P (802.4268212)


   

PI 18:2/13:3;O

PI 18:2/13:3;O

C40H67O14P (802.4268212)


   

PI 18:3/12:3;O2

PI 18:3/12:3;O2

C39H63O15P (802.3904378)


   

PI 18:4/11:3;O3

PI 18:4/11:3;O3

C38H59O16P (802.3540544)


   

PI 18:4/12:2;O2

PI 18:4/12:2;O2

C39H63O15P (802.3904378)


   

PI 20:3/11:2;O

PI 20:3/11:2;O

C40H67O14P (802.4268212)


   

PI 22:4/7:3;O3

PI 22:4/7:3;O3

C38H59O16P (802.3540544)


   

PI 22:4/8:2;O2

PI 22:4/8:2;O2

C39H63O15P (802.3904378)


   

PI 22:4/9:1;O

PI 22:4/9:1;O

C40H67O14P (802.4268212)


   

PI 22:5/7:2;O3

PI 22:5/7:2;O3

C38H59O16P (802.3540544)


   

PI 22:5/8:1;O2

PI 22:5/8:1;O2

C39H63O15P (802.3904378)


   

PI 29:7;O3

PI 29:7;O3

C38H59O16P (802.3540544)


   

PI 30:6;O2

PI 30:6;O2

C39H63O15P (802.3904378)


   

PI 31:5;O

PI 31:5;O

C40H67O14P (802.4268212)


   

[(2r,3s,4s,5r,6r)-4-hydroxy-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(2r,3s,4s,5r,6r)-4-hydroxy-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C39H62O15S (802.3809222)


   

(1s,3ar,5ar,7r,8s,9ar,9br,11ar)-8-hydroxy-3a,9a,11a-trimethyl-7-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1s,3ar,5ar,7r,8s,9ar,9br,11ar)-8-hydroxy-3a,9a,11a-trimethyl-7-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C40H66O16 (802.4350636)


   

(1s,3r,4s,5r,6r,8r,10s,23r,24r,25r,26r)-5-(acetyloxy)-4,26-dihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2e)-2-methylbut-2-enoate

(1s,3r,4s,5r,6r,8r,10s,23r,24r,25r,26r)-5-(acetyloxy)-4,26-dihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2e)-2-methylbut-2-enoate

C42H58O15 (802.3775518)


   

2-({[3-benzyl-2,5,11,14-tetrahydroxy-9-(1h-indol-3-ylmethyl)-6,7-dimethyl-8-oxo-12-(sec-butyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylbutanoic acid

2-({[3-benzyl-2,5,11,14-tetrahydroxy-9-(1h-indol-3-ylmethyl)-6,7-dimethyl-8-oxo-12-(sec-butyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylbutanoic acid

C42H58N8O8 (802.4377388)


   

[(3s,4r,5r,6s)-4-hydroxy-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-20'-oneoxy]-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(3s,4r,5r,6s)-4-hydroxy-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-20'-oneoxy]-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C38H58O16S (802.3445388)